Connected Drug Injection Devices to 2024


connected drug injection devices   Connected Drug Injection Devices • November 2018  •  Catalog no. CJD456K  •  Price US $2,850


 


For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient’s quality-of-life. Connected drug injection devices – drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs – are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

Blue document  Connected Injection Devices to 2024 Report Order Form (Download PDF)

Bar_Graph  Connected Injection Devices to 2024 Report Brochure (Download PDF)

 

  Click Here to Order Online


Connected Drug Injection Devices – What You Will Learn

• What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
• What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
• What therapeutic areas are the current focus of connected devices?
• Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations
• What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?
• What does the current market for connected drug injection devices look like? What will it look like in 2024?
• What are the key market drivers for the growth of connected injection devices?


Connected Drug Injection Devices – Summary of Contents

Executive Summary

Injectable Drug Development Trends

The Rapid Rise of Prefilled Injection Devices
Factors Driving Drug Self-Administration
Connectivity Technologies
Competitive Landscape

Connected Devices Deep Dive Analysis

Enable Wearable Injector (Enable Injections)
OmniPod (Insulet)
RebiSmart (Merck Serono)
BETACONNECT (Bayer HealthCare)
easypod (EMD Serono)
Axis-D Connect (Haselmeier)
Flexi-Q eMU (Elcam Medical)
YpsoMate/SmartPilot (Ypsomed AG)
Onejet (Biocorp)
Datapen (Biocorp)
KiCoPen (Cambridge Consultants)
Insulin Pens
InPen (Companion Medical)
Esysta Pen (Emperra)
Third Party Devices
Gocap (Common Sensing)
EASYLOG (Biocorp)
Bee (Vigilant)
Veta EpiPen Smart Case (Aterica)

Near-term Markets and Forecasts

Anaphylaxis
Autoimmune Disease
Multiple Sclerosis
Cardiovascular
Diabetes
Hormone Replacement

Market Factors

Regulatory Requirements
Data Security
Patient Acceptance

Company Profiles

 


Useful Links:

Connected Devices